Theresa Schliep

A California federal court has declined to invalidate a pair of location tracking technology patents asserted against Uber Technologies Inc., disagreeing with the company's claims that the patents are abstract and finding instead that each covers a "technical solution to a technical problem."

A split Federal Circuit panel on Wednesday supported a lower court's temporary block on Hetero Labs from selling a generic version of Otsuka's neurological disorder drug, even as it disagreed with the decision to waive Otsuka's requirement to post a bond while the case proceeds.

A Swiss company infringed IBM patents covering its mainframe software, a Western District of Texas judge found Monday, although he declined for now to give the tech giant a win on the trade secrets component of its case.

Federal Circuit Judge Pauline Newman did not ask the U.S. Supreme Court to reconsider her bid to save a suit against her fellow judges for suspending her from the bench over her refusal to undergo medical tests.

Judge Newman Won't Reopen High Court Suspension Battle

Federal Circuit Judge Pauline Newman did not ask the U.S. Supreme Court to reconsider her bid to save a suit against her fellow judges for suspending her from the bench over her refusal to undergo medical tests.

Early data on Patent Trial and Appeal Board decisions on patent eligibility determinations by examiners shows a slight dip in the affirmance rate under U.S. Patent and Trademark Office Director John Squires, according to an analysis by McDonnell Boehnen Hulbert & Berghoff LLP.

The Trademark Trial and Appeal Board has denied tennis star Serena Williams a trademark registration for the phrase "Serena Ventures" for her venture capital business, saying it's likely to be confused with an existing registration for "Serena" that covers overlapping services.

U.S. Patent and Trademark Office Director John Squires granted one petition for an America Invents Act patent review and rejected three others in his latest order on institution decisions.

A Delaware federal judge on Monday kept in place much of a jury's infringement findings against NuVasive in a doctor's case against it over a group of spinal implant patents but found the jury's other infringement conclusions weren't supported by enough evidence.